XML 49 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Financial Instruments and Fair Value Measurements (Tables)
 9 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Cash and Equivalents
The following reconciles Cash and equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets as of June 30, 2025 and September 30, 2024, to the total amounts shown in the Condensed Consolidated Statements of Cash Flows:
June 30, 2025September 30, 2024
Cash and equivalents
$230.6 $267.5 
Restricted cash
3.0 6.7 
Cash and equivalents and restricted cash
$233.6 $274.2 
Schedule of Restricted Cash
The following reconciles Cash and equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets as of June 30, 2025 and September 30, 2024, to the total amounts shown in the Condensed Consolidated Statements of Cash Flows:
June 30, 2025September 30, 2024
Cash and equivalents
$230.6 $267.5 
Restricted cash
3.0 6.7 
Cash and equivalents and restricted cash
$233.6 $274.2 
Schedule of Notional Amounts of Derivative Instruments
The notional amounts of the Company’s foreign currency-related derivative instruments were as follows as of June 30, 2025 and September 30, 2024:
Hedge DesignationJune 30, 2025September 30, 2024
Foreign exchange contracts(a)
Undesignated$2.7 $4.5 
(a)Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in Other income (expense), net. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Condensed Consolidated Financial Statements.